Exelixis Stock Investor Sentiment
| EXEL Stock | USD 36.65 0.15 0.41% |
About 60% of Exelixis' investor base is looking to short. The analysis of the overall investor sentiment regarding Exelixis suggests that many traders are alarmed. Exelixis' investing sentiment shows overall attitude of investors towards Exelixis.
Comfort Level 40
Impartial
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Exelixis' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Exelixis.
News SentimentBullish | Hype SentimentBearish | Insider SentimentDisposing |
Exelixis Historical Sentiment
Although Exelixis' investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Exelixis, such as negative comments on social media and news outlets, may cause fear in the market and push Exelixis' investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Exelixis.
Exelixis |
Exelixis Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Exelixis can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Exelixis Historical Investor Sentiment
Investor biases related to Exelixis' public news can be used to forecast risks associated with an investment in Exelixis. The trend in average sentiment can be used to explain how an investor holding Exelixis can time the market purely based on public headlines and social activities around Exelixis. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Exelixis' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Exelixis and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Exelixis news discussions. The higher the estimate score, the more favorable the investor's outlook on Exelixis.
Exelixis Maximum Pain Price Across May 16th 2025 Option Contracts
Exelixis' options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Exelixis close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Exelixis' options.
Far too much social signal, news, headlines, and media speculation about Exelixis that are available to investors today. That information is available publicly through Exelixis media outlets and privately through word of mouth or via Exelixis internal channels. However, regardless of the origin, that massive amount of Exelixis data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Exelixis news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Exelixis relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Exelixis' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Exelixis alpha.
Exelixis Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Disposition of 681 shares by Michael Morrissey of Exelixis at 20.99 subject to Rule 16b-3 | 12/20/2024 |
2 | Disposition of 27563 shares by Haley Patrick J. of Exelixis at 37.27 subject to Rule 16b-3 | 01/16/2025 |
3 | Exelixis Stock Price Up 6.7 percent on Analyst Upgrade | 02/12/2025 |
4 | Disposition of 18134 shares by Hessekiel Jeffrey of Exelixis at 35.0 subject to Rule 16b-3 | 02/19/2025 |
5 | Insider Selling Exelixis, Inc. Director Sells 12,210 Shares of Stock | 02/20/2025 |
6 | Exelixis Inc Announces Participation in Key March Investor Conferences | 02/25/2025 |
7 | Acquisition by Christopher Senner of 59648 shares of Exelixis subject to Rule 16b-3 | 02/26/2025 |
8 | Disposition of 31167 shares by Smith Julie of Exelixis at 20.5 subject to Rule 16b-3 | 02/27/2025 |
9 | Disposition of 15874 shares by Wyszomierski Jack L of Exelixis at 20.5 subject to Rule 16b-3 | 02/28/2025 |
10 | LGT Fund Management Co Ltd. Buys New Holdings in Exelixis, Inc. | 03/03/2025 |
11 | Exelixis, Inc. Shares Sold by New York Life Investment Management LLC | 03/04/2025 |
12 | Acquisition by Christopher Senner of 29314 shares of Exelixis at 18.8 subject to Rule 16b-3 | 03/07/2025 |
13 | Essex Investment Management Co. LLC Sells 1,649 Shares of Exelixis, Inc. | 03/11/2025 |
14 | Exelixis Up 13.4 percent Since Last Earnings Report Can It Continue | 03/13/2025 |
Check out Exelixis Hype Analysis, Exelixis Correlation and Exelixis Performance. For more information on how to buy Exelixis Stock please use our How to buy in Exelixis Stock guide.You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Exelixis. If investors know Exelixis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Exelixis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.754 | Earnings Share 1.76 | Revenue Per Share | Quarterly Revenue Growth 0.182 | Return On Assets |
The market value of Exelixis is measured differently than its book value, which is the value of Exelixis that is recorded on the company's balance sheet. Investors also form their own opinion of Exelixis' value that differs from its market value or its book value, called intrinsic value, which is Exelixis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Exelixis' market value can be influenced by many factors that don't directly affect Exelixis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Exelixis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Exelixis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Exelixis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.